Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS research · 2025-11-19

Clinical Trial Update: Evaluation of the Efficacy of Streptococcus Salivarius Evol12® in the Reduction of Recurrent Adenotonsillitis in Children [NA]

View source ↗

Summary

This clinical trial update reports ongoing recruitment to evaluate whether the probiotic Streptococcus Salivarius Evol12 can reduce recurrent adenotonsillitis i…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Streptococcus Salivarius Evol12

Snippet

Sponsor: Liaquat University of Medical & Health Sciences | Conditions: Recurrent Tonsillitis | NA | Status: RECRUITING